Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
35.68
-1.71 (-4.57%)
Feb 21, 2025, 4:00 PM EST - Market closed
Astrana Health Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Astrana Health stock have an average target of 65.6, with a low estimate of 50 and a high estimate of 86. The average target predicts an increase of 83.86% from the current stock price of 35.68.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Astrana Health stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $70 → $56 | Strong Buy | Maintains | $70 → $56 | +56.95% | Feb 20, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $59 → $50 | Strong Buy | Maintains | $59 → $50 | +40.13% | Jan 13, 2025 |
| Baird | Baird | Buy Maintains $67 → $86 | Buy | Maintains | $67 → $86 | +141.03% | Nov 13, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates $66 | Strong Buy | Initiates | $66 | +84.98% | Oct 14, 2024 |
| Keybanc | Keybanc | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 11, 2024 |
Financial Forecast
Revenue This Year
2.03B
from 1.39B
Increased by 46.11%
Revenue Next Year
2.72B
from 2.03B
Increased by 34.25%
EPS This Year
1.18
from 1.29
Decreased by -8.87%
EPS Next Year
1.45
from 1.18
Increased by 23.07%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 2.1B | 3.4B | 4.5B | |||
| Avg | 2.0B | 2.7B | 3.4B | |||
| Low | 1.9B | 2.3B | 2.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 53.6% | 69.5% | 66.1% | |||
| Avg | 46.1% | 34.3% | 24.2% | |||
| Low | 37.8% | 11.6% | -3.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.30 | 1.76 | 2.34 |
| Avg | 1.18 | 1.45 | 1.94 |
| Low | 1.05 | 0.97 | 1.38 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.9% | 50.1% | 61.9% |
| Avg | -8.9% | 23.1% | 34.0% |
| Low | -18.7% | -17.5% | -4.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.